We have located links that may give you full text access.
English Abstract
Journal Article
[Pathophysiology and advances in the treatment of Hereditary Angioedema].
Revista Alergia Mexico : Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C 2011 March
Hereditary angioedema is an autosomic dominant disease, caracterized by recurrent angioedema and caused by a defective enzime known as C1 inhibitor. The main mediator involved in the development of angioedema is bradikynin. There are three types of the disease, the first one related to a decrease in the production of the enzime, the second one caracterized by an altered function of the enzime and the third one due to an altered factor XII gene. The recurrent angioedema may be localized in the periphery, in the gastrointestinal system or laryngeal, the last one being life threatening. For its treatment there are a lot of drugs available, such as attenuated androgens, fresh frozen plasma, tranexamic acid or the enzime substitution by a C1 inhibitor concentrate purified from plasma, nanofiltered or recombinant. Recently, treatment has been directed toward the avoidance of baradykinin production or its action through its B2 receptor.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app